CCR5 and p53 codon 72 gene polymorphisms: Implications in breast cancer development

  • Authors:
    • Mateus Nobrega Aoki
    • Ana Cristina da silva do amaral Herrera
    • Marla Karine Amarante
    • Juliana Laino do Val Carneiro
    • Maria Helena Pelegrinelli Fungaro
    • Maria Angelica Ehara Watanabe
  • View Affiliations

  • Published online on: March 1, 2009     https://doi.org/10.3892/ijmm_00000148
  • Pages: 429-435
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of this study was to investigate the CCR5 gene and p53 codon 72 polymorphisms in a Brazilian population with breast cancer compared with healthy control subjects and to associate the clinical stage with these genotypes. No differences were detected for the D32 allele between breast cancer patients and the normal healthy donors (p=0.270), although this allele was more often present in blood donors. For p53 genotype analysis, breast cancer patients presented a significant (p<0.05) over-representation of p53 Arg homozygosity (55.5%) compared with the healthy control group (33.3%). Although no statistical difference occurred, a very strong tendency in breast cancer patients in stage III (p=0.0503) presenting homozygous genotype for Arg was verified. Five breast cancer patients were D32 deletion carriers and two patients presenting metastasis showed homozygous genotype for Arg. It is possible that p53 Arg homozygosity is associated with breast cancer and may represent a potential risk factor for breast tumorigenesis. In the present study, a higher percentage of breast cancer patients presented homozygous genotype for Arg and wild-type for CCR5 than the control subjects.

Related Articles

Journal Cover

March 2009
Volume 23 Issue 3

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Aoki MN, da silva do amaral Herrera AC, Amarante MK, do Val Carneiro JL, Fungaro MH and Watanabe MA: CCR5 and p53 codon 72 gene polymorphisms: Implications in breast cancer development. Int J Mol Med 23: 429-435, 2009.
APA
Aoki, M.N., da silva do amaral Herrera, A.C., Amarante, M.K., do Val Carneiro, J.L., Fungaro, M.H., & Watanabe, M.A. (2009). CCR5 and p53 codon 72 gene polymorphisms: Implications in breast cancer development. International Journal of Molecular Medicine, 23, 429-435. https://doi.org/10.3892/ijmm_00000148
MLA
Aoki, M. N., da silva do amaral Herrera, A. C., Amarante, M. K., do Val Carneiro, J. L., Fungaro, M. H., Watanabe, M. A."CCR5 and p53 codon 72 gene polymorphisms: Implications in breast cancer development". International Journal of Molecular Medicine 23.3 (2009): 429-435.
Chicago
Aoki, M. N., da silva do amaral Herrera, A. C., Amarante, M. K., do Val Carneiro, J. L., Fungaro, M. H., Watanabe, M. A."CCR5 and p53 codon 72 gene polymorphisms: Implications in breast cancer development". International Journal of Molecular Medicine 23, no. 3 (2009): 429-435. https://doi.org/10.3892/ijmm_00000148